Advanced Search

 

Study ID Status Title Patient Level Data
117044 Completed Efficacy, safety and tolerability of amoxicillin + clavulanic acid (875mg/125mg) two times a day compared to clindamycin (150mg) four times a day for 5-7 days in treatment of acute odontogenic infection with or without abscess Study Listed on ClinicalStudyDataRequest.com
117051 Completed WEUSKOP6166: Prevalence of Aseptic Meningitis among Lamotrigine users
117057 Completed An Open-label, Randomized, Single Dose, three-way Crossover study to determine the Bioavailability of Two Fixed Dose Combination Capsule Formulations of Dutasteride and Tamsulosin Hydrochloride (0.5mg/0.2mg) Relative to Co-administration of Dutasteride 0.5mg capsules and Tamsulosin Hydrochloride 0.2mg tablets in Healthy Male Subjects in the fed and fasted states Study Listed on ClinicalStudyDataRequest.com
117058 Completed A Four Way Crossover Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies
117059 Terminated OPV117059: A Long-Term Extension Study of Ofatumumab Injection for Subcutaneous Use in Subjects with Pemphigus Vulgaris
117084 Completed Latin America Observational Study on Epilepsy Patients
117100 Completed A Randomized, Parallel-Group, Open-Label Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Administered Subcutaneously to Healthy Subjects by Prefilled Syringe or Autoinjector Study Listed on ClinicalStudyDataRequest.com
117104 Completed A Randomized, Double Blinded, Parallel Study to Evaluate the Pharmacokinetics of Zanamivir after Single and Repeated Dose (300 mg and 600 mg) Infusion Administration in Healthy Chinese Adults
117115 Completed A multicenter, trial comparing the efficacy and safety of Umeclidinium/Vilanterol 62.5/25 mcg once daily with Tiotropium 18 mcg once daily over 24 weeks in subjects with Chronic Obstructive Pulmonary Disease (COPD). Study Listed on ClinicalStudyDataRequest.com
117119 Completed Immunogenicity and safety study of GSK Biologicals’ Infanrix hexa at 2, 4 and 6 months of age in healthy infants
117120 Completed Study of bioequivalence between two formulations of 20 mg rosuvastatin calcium tablets, administered under fasting to healthy volunteers of both genders, being the test formulation manufactured by Laboratorios Phoenix S.A.I.C.F/Argentina for GlaxoSmithKline Brasil Ltda. and the reference formulation (Crestor®) commercialized by AstraZeneca do Brasil Ltda.
117134 Completed A Phase IIa Study of the MEK Inhibitor GSK1120212 Monotherapy in the Treatment of Gemcitabine refractory Locally Advanced, Recurrent or Metastatic Biliary Tract Cancers
117150 Completed A Multicenter, Open-Label Study To Assess The Efficacy And Safety Of Potassium Clavulanate/Amoxicillin (CVA/AMPC 1:14 combination) In The Treatment Of Children With Acute Bacterial Rhinosinusitis Study Listed on ClinicalStudyDataRequest.com
117151 Completed A Study to Evaluate the Feasibility of Microdialysis to Determine Skin Concentrations of Retapamulin in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
117155 Terminated An Open Label Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F-GSK2647544 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
117156 Completed A randomised, repeat-dose, placebo-controlled, three-way crossover, double dummy study to evaluate and compare the efficacy of Fluticasone Furoate inhalation powder delivered via the single strip dry powder inhaler when administered either in the morning or in the evening, in male and female asthmatic subjects Study Listed on ClinicalStudyDataRequest.com
117157 Completed Characterization of Exposure from Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
117168 Completed A Phase I, Subject and Investigator Blind Randomized, Study to Investigate the Pharmacokinetics, Safety and Tolerability of Retosiban in Healthy Japanese Women
117170 Active, Not Recruiting Analysis Plan for the Integrated Analysis of Cardiovascular Risk Among Type II Diabetes Subjects Exposed to GSK716155 in the Phase III Program
117171 Completed A two-part healthy volunteer study to investigate both the interaction of GSK2586184 with Rosuvastatin and Simvastatin and to compare the pharmacokinetics of two different formulations of GSK2586184
117176 Completed AN OPEN LABEL, BALANCED, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, SINGLE ORAL DOSE, BIOEQUIVALENCE STUDY OF MELOXICAM GSK 15 MG TABLETS MANUFACTURED BY SAVIPHARM J.S.C, VIETNAM AND MOBIC® 15 MG TABLETS OF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG BINGER STR.173, 5521 INGELHEIM AM RHEIN, GERMANY, IN HEALTHY, ADULT, HUMAN MALE SUBJECTS UNDER FED CONDITION.
117177 Completed Consistency, immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults 50 years of age or older
117183 Completed Efficacy and safety of alitretinoin in the treatment of severe chronic hand eczema refractory to topical therapy
117191 Completed An Evaluator-Blinded Study to Evaluate the Cumulative Irritation Potential of Topically-Applied GSK2894512 Cream in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
117211 Completed Plan to Assess the incidence of cardiovascular related adverse events in controlled clinical trials of bupropion for the treatment of smoking cessation

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.